Results 191 to 200 of about 23,011 (205)

Anti-CD30 antibodies and methods for treating CD30+ cancer

2023
MEDIN JEFFREY A, FABER MARY L, TATE EVERETT R, OLDHAM ROBYN A A   +3 more
openaire   +1 more source

CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: Evidence for a T helper 2-mediated condition

European Journal of Immunology, 1996
Marco Chilosi, Luigi Notarangelo, Fabio Facchetti   +2 more
exaly  

CAR-CD30 T CELLS FOR TREATMENT OF CD30+ TUMORS

2019
DE ANGELIS BIAGIO, QUINTARELLI CONCETTA, CARUANA IGNAZIO, LOCATELLI FRANCO   +3 more
openaire   +3 more sources

CD30—Governor of Memory T Cells?

Annals of the New York Academy of Sciences, 2002
Nataša Strbo
exaly  

High levels of the soluble form of CD30 molecule in rheumatoid arthritis (RA) are expression of CD30+ T cell involvement in the inflamed joints

Clinical and Experimental Immunology, 2008
Roberto Gerli, Brunangelo Falini, O Bistoni   +2 more
exaly  

VIRAL CD30 POLYPEPTIDE

2003
ALCAMI ANTONIO, SARAIVA MARGARIDA
openaire   +3 more sources

Preferential expression of CD30 by human CD4 + T cells producing Th2‐type cytokines

FASEB Journal, 1995
exaly  

Optimized anti-CD30 antibodies

2011
LAZAR GREGORY ALAN, DESJARLAIS JOHN R, HAMMOND PHILIP W, CARMICHAEL DAVID F, CHEN BAO-IU, CHU SEUNG Y, KARKI SHER BAHADUR, KUNKEL LORI   +7 more
openaire   +4 more sources

CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma

Case Medical Research, 2019
openaire   +1 more source

CD30 ligand

1996
GOODWIN RAYMOND G, SMITH CRAIG A, ARMITAGE RICHARD J, GRUSS HANS-JUERGEN   +3 more
openaire   +2 more sources